Onesource Specialty Pharma Ltd.
National Stock Exchange of IndiaTotal Valuation
Onesource Specialty Pharma Ltd. carries a market capitalization of 190.67B, placing it among publicly traded companies globally. Its enterprise value stands at 174.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 190.67B |
| Enterprise Value | 174.51B |
Share Statistics
Onesource Specialty Pharma Ltd. currently has 114.62M shares outstanding.
| Shares Outstanding | 114.62M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Onesource Specialty Pharma Ltd. trades at a trailing price-to-earnings ratio of 1,483.89. The price-to-sales ratio is 11.30, and the price-to-book ratio stands at 1,401.73.
| PE Ratio | 1,483.89 |
| PS Ratio | 11.30 |
| PB Ratio | 1,401.73 |
| P/TBV Ratio | 30.64 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Onesource Specialty Pharma Ltd. trades at an EV/EBITDA multiple of 694.46 and an EV/FCF ratio of 177.97. The EV/Sales ratio of 12.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 694.46 provides insight into valuation relative to core operating earnings.
| EV / Sales | 12.28 |
| EV / EBITDA | 694.46 |
| EV / EBIT | 694.46 |
| EV / FCF | 177.97 |
Financial Position
Onesource Specialty Pharma Ltd. maintains a current ratio of 0.99, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.79, indicating elevated leverage, while an interest coverage ratio of 0.21 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.99 |
| Quick Ratio | 0.08 |
| Debt / Equity | 25.79 |
| Debt / EBITDA | 59.85 |
| Interest Coverage | 0.21 |
Financial Efficiency
| Return on Equity (ROE) | 697.73 |
| Return on Assets (ROA) | -0.94 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | -181.58M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Onesource Specialty Pharma Ltd.'s stock has declined approximately -16.77009% over the past 52 weeks. The 50-day moving average sits at 1,735.84, while the 200-day moving average is 1,620.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.77009% |
| 50-Day Moving Average | 1,735.84 |
| 200-Day Moving Average | 1,620.31 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Onesource Specialty Pharma Ltd. generated 14.22B in revenue and converted that into -738.03M in net income, yielding earnings per share of -6.74. EBITDA reached 251.29M, while operating income came in at 251.29M.
| Revenue | 14.22B |
| Gross Profit | 9.75B |
| Operating Income | 251.29M |
| Pretax Income | -919.61M |
| Net Income | -738.03M |
| EBITDA | 251.29M |
| EBIT | 251.29M |
| Earnings Per Share (EPS) | -6.74 |
Balance Sheet
Onesource Specialty Pharma Ltd. holds 1.19B in cash and equivalents against 15.04B in total debt, resulting in a net debt position of 12.41B. Total book value stands at 114.62M, with working capital of -160.29M providing operational flexibility.
| Cash & Cash Equivalents | 1.19B |
| Total Debt | 15.04B |
| Net Debt | 12.41B |
| Equity (Book Value) | 114.62M |
| Book Value Per Share | 1.05 |
| Working Capital | -160.29M |
Margins
Onesource Specialty Pharma Ltd. operates with a gross margin of 68.55, reflecting its pricing power and cost economics. The operating margin of 1.77 and net profit margin of -5.19 provide insight into operational efficiency.
| Gross Margin | 68.55 |
| Operating Margin | 1.77 |
| Pretax Margin | -6.47 |
| Profit Margin | -5.19 |
| EBITDA Margin | 1.77 |
Scores
Onesource Specialty Pharma Ltd. posts an Altman Z-Score of 4.56, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.56 |